Fall 2012 makeup was confident and sultry as lipstick made a comeback, at the expense of lip gloss, and eyes shouted sex appeal with dramatic eyeliner and bold brows. That’s the look that graced fashion runways, and judging by the numbers, consumers followed suit in the mass market.
Sales of color cosmetics lost some of its shimmer during the recession as beauty mavens reduced purchase cycles, traded down to value brands and cut back on experimenting with new products. However, consumers are returning to the category, which is likely to spell strong sales for spring and beyond.
In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.
Improving medication adherence in specialty pharmacy could be equivalent to introducing a new blockbuster drug. That’s how Diplomat Specialty Pharmacy president and CEO Phil Hagerman put it at Drug Store News’ Specialty Pharmacy Roundtable two years ago.
As evidenced by data provided by SymphonyIRI Group, a Chicago-based market research firm, the bath and body segment is lacking some of its lather as sales of bath/body scrubbers and body wash took a dip.
It is clearly no secret that nail care products at mass are red hot, as manufacturers continue to develop innovative do-it-yourself products that imitate nail salon effects and beauty mavens increasingly turn to at-home, cost-effective solutions.